NCT02704260

Brief Summary

search for a genetic cause of vascular endofibrose

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2016

Completed
8 days until next milestone

Study Start

First participant enrolled

March 2, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 9, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2016

Completed
Last Updated

November 1, 2017

Status Verified

December 1, 2016

Enrollment Period

6 months

First QC Date

February 23, 2016

Last Update Submit

October 30, 2017

Conditions

Genetic Syndrome

Outcome Measures

Primary Outcomes (1)

  • Presence of mutations or nucleotides variations

    DNA analysis and search for genetic mutations

    1 hour

Study Arms (1)

GENETIC ANALISYS

EXPERIMENTAL

GENETIC ANALYSIS AND RESEARCH OF GENETIC BLOOD SAMPLE

Genetic: GENETIC ANALYSIS

Interventions

GENETIC ANALYSISGENETIC

prélevement blood to search for a genetic cause of vascular endofibrose. Search genetic mutations in 5 subjects.

GENETIC ANALISYS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • High level reached Cyclists vascular endofibrose
  • Cyclist high level and not sick with a brother or sister is senior cyclist reaches the vascular endofibrose.

You may not qualify if:

  • not obtaining consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Angers, 49933, France

Location

MeSH Terms

Conditions

Genetic Diseases, Inborn

Interventions

Genetic Testing

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesGenetic TechniquesGenetic ServicesHealth ServicesHealth Care Facilities Workforce and ServicesDiagnostic ServicesPreventive Health Services

Study Officials

  • PIERRE ABRAHAM, PROFESSOR

    UH ANGERS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2016

First Posted

March 9, 2016

Study Start

March 2, 2016

Primary Completion

September 2, 2016

Study Completion

September 2, 2016

Last Updated

November 1, 2017

Record last verified: 2016-12

Locations

FR(1)